BVS – bioventus inc. - class a (US:NASDAQ)
Stock Stats
News
Bioventus (NASDAQ:BVS) was upgraded by analysts at Barrington Research to a "strong-buy" rating.
Bioventus (NYSE:BVS) is now covered by analysts at Barrington Research. They set an "outperform" rating and a $13.00 price target on the stock.
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference [Yahoo! Finance]
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
Form 4 Bioventus Inc. For: Feb 15 Filed by: Singleton Mark Leonard
Form 4 Bioventus Inc. For: Feb 15 Filed by: CHURCH KATRINA J
Form 4 Bioventus Inc. For: Feb 15 Filed by: D'Adamio Anthony
Form SCHEDULE 13G/A Bioventus Inc. Filed by: Nantahala Capital Management, LLC
Form 4 Bioventus Inc. For: Jan 09 Filed by: Claypoole Robert E
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.